Literature DB >> 25973057

Prognostic significance and anti-proliferation effect of microRNA-365 in hepatocellular carcinoma.

Zhizhao Chen1, Zufa Huang1, Qifa Ye1, Yingzi Ming1, Sheng Zhang1, Yujun Zhao1, Lian Liu1, Qiang Wang1, Ke Cheng1.   

Abstract

MircroRNA functions as tumor suppressor or promoter in hepatocellular carcinoma (HCC). Researchers have found that miR-365 expression was lower in HCC tissues compared with that in adjacent normal tissues. However, its prognostic significance and anti-proliferation effect in HCC remain to be clarified. In this study, we firstly found that miR-365 expression was lower in HCC tissues compared with that in adjacent normal tissues. Then, we analyzed miR-365 expression level and its clinicopathological and prognostic significance. Finally, overexpression of miR-365 inhibits HCC cell proliferation and migration in vitro. Our findings suggest that miR-365 expression was an independent poor prognostic factor for HCC patient overall survival and suppressed tumor cell growth. Therefore, miR-365 may serve as a valuable prognostic marker and promising target for HCC.

Entities:  

Keywords:  hepatocellular carcinoma; miR-365; prognosis; proliferation

Mesh:

Substances:

Year:  2015        PMID: 25973057      PMCID: PMC4396306     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

Review 2.  Treatment of hepatocellular carcinoma.

Authors:  Alejandro Forner; Amelia J Hessheimer; M Isabel Real; Jordi Bruix
Journal:  Crit Rev Oncol Hematol       Date:  2006-07-24       Impact factor: 6.312

Review 3.  MicroRNAs and cancer: past, present, and potential future.

Authors:  Kristen M Nelson; Glen J Weiss
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

Review 4.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

Authors:  Hashem B El-Serag; K Lenhard Rudolph
Journal:  Gastroenterology       Date:  2007-06       Impact factor: 22.682

Review 5.  MicroRNAs in cancer.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

6.  Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes.

Authors:  Ping Xie; Chunyan Tian; Liguo An; Jing Nie; Kefeng Lu; Guichun Xing; Lingqiang Zhang; Fuchu He
Journal:  Cell Signal       Date:  2008-06-27       Impact factor: 4.315

7.  Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Authors:  Jinmai Jiang; Yuriy Gusev; Ileana Aderca; Teresa A Mettler; David M Nagorney; Daniel J Brackett; Lewis R Roberts; Thomas D Schmittgen
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

8.  MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.

Authors:  Hang Su; Jian-Rong Yang; Teng Xu; Jun Huang; Li Xu; Yunfei Yuan; Shi-Mei Zhuang
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

9.  MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.

Authors:  Shoumei Bai; Mohd W Nasser; Bo Wang; Shu-Hao Hsu; Jharna Datta; Huban Kutay; Arti Yadav; Gerard Nuovo; Pawan Kumar; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

Review 10.  Molecular mechanisms of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli; Clifford J Steer; Erik N K Cressman
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

View more
  18 in total

1.  MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.

Authors:  Kejia Wang; Qing Liang; Li Wei; Wei Zhang; Ping Zhu
Journal:  Tumour Biol       Date:  2015-10-16

2.  Prognostic significance of microRNA-203 in cholangiocarcinoma.

Authors:  Jingjing Li; Beibei Gao; Zufa Huang; Tong Duan; Daiqiang Li; Sheng Zhang; Yujun Zhao; Lian Liu; Qiang Wang; Zhizhao Chen; Ke Cheng
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.

Authors:  Yongli Zhao; Fenbao Li; Xizhong Zhang; Aiguang Liu; Jinsong Qi; Hongkai Cui; Peng Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a.

Authors:  Yanli Wang; Chunling Xu; Yun Wang; Xiaomeng Zhang
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

5.  miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients.

Authors:  Ze-Bin Jiang; Bing-Qiang Ma; Zongfeng Feng; Shao-Guang Liu; Peng Gao; Hui-Ting Yan
Journal:  Cell Cycle       Date:  2021-01-18       Impact factor: 4.534

6.  A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.

Authors:  Ji-Guang Han; Yong-Dong Jiang; Chun-Hui Zhang; Yan-Mei Yang; Da Pang; Yan-Ni Song; Guo-Qiang Zhang
Journal:  Ann Surg Treat Res       Date:  2017-01-31       Impact factor: 1.859

7.  Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.

Authors:  Yue Zhang; Chao Wei; Cong-Cong Guo; Rong-Xiu Bi; Jin Xie; Dong-Hui Guan; Chuan-Hua Yang; Yue-Hua Jiang
Journal:  Oncotarget       Date:  2017-09-14

8.  Utility of miR‑133a‑3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta‑analysis and bioinformatics.

Authors:  Hai-Wei Liang; Xia Yang; Dong-Yue Wen; Li Gao; Xiang-Yu Zhang; Zhi-Hua Ye; Jie Luo; Zu-Yun Li; Yun He; Yu-Yan Pang; Gang Chen
Journal:  Mol Med Rep       Date:  2017-11-14       Impact factor: 2.952

9.  miRNA signatures can predict acute liver failure in hepatitis E infected pregnant females.

Authors:  Nirupma Trehanpati; Rashi Sehgal; Sharda Patra; Ashish Vyas; Madavan Vasudevan; Ritu Khosla; Arshi Khanam; Guresh Kumar; Rakhi Maiwall; Gayatri Ramakrishna; Shyam Kottilil; Shiv Kumar Sarin
Journal:  Heliyon       Date:  2017-04-06

Review 10.  Emerging genotype-phenotype relationships in patients with large NF1 deletions.

Authors:  Hildegard Kehrer-Sawatzki; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2017-02-17       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.